Regenerative medicine · Partner-clinic service
A structured pathway to understand whether a cell-based programme may be appropriate—starting with medical rationale, evidence, product verification and a qualified provider's assessment.
Clear language first
“Stem Cell Programme” is the simple service name. The technical formulation discussed with the partner clinic is P2 MSC 100M.
MSC generally refers to mesenchymal stromal or stem cells. P2 commonly refers to an early cell-culture passage, while 100M describes the intended cell count. These terms alone do not establish quality, suitability or expected results.
The treating provider should confirm the actual cell source, identity, processing standard, viable cell count, sterility testing, storage, regulatory status, route of administration and clinical rationale before consent.
Due diligence before treatment
A premium experience should include more than a product name. It should make the medical reasoning, quality controls and aftercare understandable.
The provider should define the health concern being assessed and why a cell-based option is being considered.
Ask for traceable information about the product and the professionals responsible for your care.
Informed consent should cover what happens before, during and after the programme.
Your evaluation pathway
Share the health question you want assessed, not simply the treatment you want to buy.
A qualified partner provider reviews history, medicines, allergies and relevant records.
The provider discusses suitability, uncertainties, alternatives and whether further tests are needed.
Only eligible clients proceed, with written consent, monitoring and an agreed aftercare plan.
Bring these to consultation
Pause before proceeding
Stem Cell Programme FAQ
The treating provider—not MenHealthWellness—makes all clinical decisions.
No. “Stem Cell Programme” is the consumer-friendly service name. P2 MSC 100M is a technical formulation description that must be confirmed and explained by the partner provider.
Suitability depends on the intended clinical use, medical history, examination, current evidence, product status and provider assessment. It cannot be determined from an online enquiry alone.
Bring a medication and allergy list, relevant diagnoses, recent laboratory or imaging reports and details of prior treatments. Use the provider's secure channel for sensitive records.
No. Individual outcomes vary, evidence differs by indication, and some proposed uses may be investigational or not authorised in a particular country.
No. MenHealthWellness is an independent information and coordination platform. Medical assessment, consent and treatment are provided by separate licensed healthcare providers.
Complimentary and confidential
Tell us what you want to understand. We can coordinate an appropriate partner-clinic conversation without assuming that a treatment is right for you.
Explore other services